» Authors » Natasa Skalko-Basnet

Natasa Skalko-Basnet

Explore the profile of Natasa Skalko-Basnet including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 97
Citations 1322
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
11.
Giambelluca M, Markova E, Louet C, Steinkjer B, Sundset R, Skalko-Basnet N, et al.
Nanomedicine . 2023 Oct; 54:102712. PMID: 37838100
Nanomedicine holds immense potential for therapeutic manipulation of phagocytic immune cells. However, in vitro studies often fail to accurately translate to the complex in vivo environment. To address this gap,...
12.
Sousa A, Boroy V, Baeverud A, Julin K, Bayer A, Strom M, et al.
J Mater Chem B . 2023 Jul; 11(33):7972-7985. PMID: 37505112
Nucleic acid-based materials showcase an increasing potential for antimicrobial drug delivery. Although numerous reports on drug-loaded DNA nanoparticles outline their pivotal antibacterial activities, their potential as drug delivery systems against...
13.
Hemmingsen L, Panzacchi V, Kangu L, Giordani B, Luppi B, Skalko-Basnet N
Pharmaceuticals (Basel) . 2023 Jun; 16(6). PMID: 37375738
The main focus when considering treatment of non-healing and infected wounds is tied to the microbial, particularly bacterial, burden within the wound bed. However, as fungal contributions in these microbial...
14.
cacic A, Amidzic Klaric D, Keser S, Radikovic M, Rukavina Z, Joraholmen M, et al.
Pharmaceutics . 2023 May; 15(5). PMID: 37242598
Biocompatible mucoadhesive formulations that enable a sustained drug delivery at the site of action, while exhibiting inherent antimicrobial activity, are of great importance for improved local therapy of vaginal infections....
15.
Hemmingsen L, Giordani B, Paulsen M, Vanic Z, Flaten G, Vitali B, et al.
Biomater Adv . 2022 Dec; 145:213238. PMID: 36527962
The eradication of bacteria embedded in biofilms is among the most challenging obstacles in the management of chronic wounds. These biofilms are found in most chronic wounds; moreover, the biofilm-embedded...
16.
Hemmingsen L, Panchai P, Julin K, Basnet P, Nystad M, Johannessen M, et al.
Front Microbiol . 2022 Oct; 13:1023083. PMID: 36246245
Infected chronic skin wounds and other skin infections are increasingly putting pressure on the health care providers and patients. The pressure is especially concerning due to the rise of antimicrobial...
17.
Mari Holsaeter A, Wizgird K, Karlsen I, Hemmingsen J, Brandl M, Skalko-Basnet N
Eur J Pharm Sci . 2022 Jul; 177:106267. PMID: 35872073
Limitations of the anticancer drug product Taxotere® have encouraged researchers to entrap the active ingredient docetaxel (DTX) into nanocarriers such as liposomes. However, until now no DTX-liposome formulation has reached...
18.
Joraholmen M, Damdimopoulou P, Acharya G, Skalko-Basnet N
Pharmaceutics . 2022 Jun; 14(6). PMID: 35745867
The natural polyphenol resveratrol (RES) has shown great potential as an antimicrobial, including against microbes associated with vaginal infections. To fully exploit the activities of RES, an all-natural ingredients formulation...
19.
Rustad E, von Hofsten S, Kumar R, Laensman E, Berge G, Skalko-Basnet N
Pharmaceutics . 2022 Jun; 14(6). PMID: 35745698
Nanomedicine has been, to a certain degree, a success story in the development of superior anticancer therapies. However, there are tumors that remain a huge challenge for nanoformulations, for instance,...
20.
Hemmingsen L, Skalko-Basnet N, Joraholmen M
Mar Drugs . 2021 Dec; 19(12). PMID: 34940696
Chitosan is one of the most studied natural origin polymers for biomedical applications. This review focuses on the potential of chitosan in localized antimicrobial therapy to address the challenges of...